Prostate Cancer Blog

Radioligand Therapy With 177Lu-PSMA-617 – A Novel Therapeutic Possibility on the Horizon in Men With Metastatic Castration Resistant Prostate Cancer.

We are seeing more and more novel therapies being developed to treat castrate resistant metastatic prostate cancer (mCRPC). One such therapy involves theranostic (individualized therapies for various diseases, and to combine diagnostic and therapeutic capabilities into a single agent) concepts using radiolabeled ligands of the prostate-specific membrane antigen (PSMA). In a recent study, designed to [...]

By Malecare|2016-04-28T16:08:19-04:00April 28th, 2016|Advanced Prostate Cancer, Clinical Trials & Research, Drugs & Treatments, On The Horizon, Survival, survival, Uncategorized|2 Comments

Radiotherapy Might Not Extend Survival In Men With Prostate Cancer Who Are Under 70 Years Old

Increasingly, we are seeing younger men diagnosed with prostate cancer and with bone metastases. One of the more common therapies, radiotherapy is recognized for its effect on local control of bone metastases, but whether it could prolong overall survival, the gold standard is still controversial. Researchers retrospectively evaluated 113 men with prostate cancer and bone [...]

By Malecare|2020-02-04T10:41:23-05:00April 27th, 2016|Advanced Prostate Cancer, Drugs & Treatments, Radiotherapy, Survival, Uncategorized|0 Comments

Understanding Prostate Cancer Clinical Trials – Types and Stages

The decision to enroll in a clinical trial should involve a discussion between the person with prostate cancer and that individual’s physician. Your participation should depend on many factors, including your motivation for enrolling in a trial, the stage of your prostate cancer, and the trials available and its phase. When you decide to enroll in a clinical [...]

By Malecare|2017-10-19T10:46:22-04:00April 26th, 2016|Advanced Prostate Cancer, Clinical Trials, Clinical Trials & Research, Uncategorized, Understanding Advanced Prostate Cancer|3 Comments

Happy DNA Day!

Happy DNA Day! First celebrated in 2003 by proclamation of the Senate and the House of Representatives, the holiday commemorates the day James Watson, Francis Crick, Maurice Wilkins and Rosalind Franklin first published their papers on the structure of DNA. The reason for the proclamation In 2003 it was announced that the Human Genome Project [...]

By Malecare|2021-02-17T10:41:16-05:00April 25th, 2016|Advanced Prostate Cancer, Advocacy, Uncategorized|0 Comments

Recurring Prostate Cancer- What ADT Treatment Schedule Is Superior?

One of the many constantly recurring topics that we discuss is over the efficacy of intermittent hormone deprivation therapy (IAD) as opposed to continuous hormone deprivation therapy (CAD). Which therapy is better has been debated for at least ten years. The debate still rages over the question of efficacy, or survival as well as the [...]

By Malecare|2023-07-08T15:57:45-04:00April 25th, 2016|Advanced Prostate Cancer, Clinical Trials, Drugs & Treatments, Europe, Hormone Therapy, Quality of Life, Uncategorized, Understanding Advanced Prostate Cancer|0 Comments

Tips To Reduce The Cancer Risk Of Grilling Meat And Other Food Ideas To Consider

If you are like me then you enjoy eating grilled meat. I know, eating red meat isn’t going to be healthy, but I still enjoy it and I long ago decided that eating, in moderation, the foods I enjoy is a trade off I am willing to do as I live my life. However, I [...]

By Malecare|2017-10-19T10:46:24-04:00April 20th, 2016|Advanced Prostate Cancer, Diet, Diet, Exercise and Supplements, survivorship, Uncategorized|0 Comments

How To Get A Blood Test For AR-V7 If You Have Castrate Resistant Prostate Cancer

In the near future we should be seeing more non-invasive methods to evaluate if a man is responding to their drugs. One such example is the blood bio-marker available only at Johns Hopkins, the Androgen Receptor Variant 7 (AR-V7). Evaluating the presence of the antibody AR-V7 in the blood strongly indicates whether or not both [...]

By Malecare|2020-02-04T12:38:24-05:00April 19th, 2016|Advanced Prostate Cancer, Anti-Bodies, AR-V7 Splice Varient, Uncategorized|0 Comments

High Volume Radiation Treatment Facilities Produce Better Survival In Men with Aggressive Prostate Cancer

According to researchers at Brigham and Women’s Hospital in Boston Ma., men with aggressive prostate cancer who have radiation therapy to treat the cancer have better overall survival rates when the therapy is given at a high volume treatment facility. Paul Nguyen, MD, a physician researcher in the department of Radiation Oncology at Brigham said, “Our paper shows that [...]

By Malecare|2023-07-08T15:57:45-04:00April 12th, 2016|Advanced Prostate Cancer, Drugs & Treatments, General Information, Radiation, Radiotherapy, Research, Survival, Uncategorized|0 Comments

Salvage Radical Prostatectomy Improves Long Term Survival in Men with Radiation Recurrent Prostate Cancer

A retrospective study, using the SEER Date, a U.S. national database, analyzed data from men diagnosed with prostate cancer and found that salvage radical prostatectomy (SRP) improved the long-term survival in men whose cancer has returned after receiving radiation therapy. We know that approximately 30% of men who have radiation therapy as their primary therapy will have a recurrence [...]

By Malecare|2023-07-08T15:57:45-04:00April 11th, 2016|Advanced Prostate Cancer, Drugs & Treatments, General Information, Radiotherapy, salvage therapy, Uncategorized|0 Comments

Belfast Clinical Trial Combining Two Radio-Therapies For Men With Advanced Prostate Cancer

Researchers at Queen’s University in Belfast along with the Belfast Trust are conducting a clinical trial evaluating the combination of two radiotherapy treatments, Radium 223 and Pelvic Radiation using Volumetric Modulated Arc Therapy (VMAT) in men with bone positive advanced prostate cancer. The trial, being called ADRRAD trial, involves combining androgen deprivation therapy (ADT) along [...]

By Malecare|2016-04-08T12:27:32-04:00April 8th, 2016|Advanced Prostate Cancer, Alpharadin (radium-223), Bone Metastases, Bones and Prostate Cancer, Clinical Trials, Clinical Trials & Research, Drugs & Treatments, Radiotherapy, Uncategorized, United Kingdom - England, Northern Ireland, Scotland & Wales, Xofigo|2 Comments